Compounded semaglutide cost analysis for 2026 — starting prices, maintenance pricing, flat-rate vs dose-tiered, total 12-month cost across 10+ providers.
Compounded semaglutide telehealth costs in 2026 range from $1,740/year (NexLife flat-rate $145/mo on the 12-month plan (see pricing log)) to $3,400+/year (teaser-priced competitors that rise from $99 to $250–$400 at maintenance dose). Brand-name Wegovy cash-pay is $15,600+/year. The cost difference between flat-rate and dose-tiered providers over 12 months is typically $900–$1,800.
Patients comparing compounded semaglutide telehealth options on a 12-month-cost basis. Patients understanding the difference between flat-rate, dose-tiered, membership-stacked, per-visit, and brand-cash pricing structures.
Patients seeking insurance-covered semaglutide — compounded is generally not insurance-eligible. Talk with your primary clinician about brand-name Wegovy with insurance coverage as the lowest-cost alternative when accessible.
| Provider | Starting | Maintenance | 12-mo total | Pricing structure |
|---|---|---|---|---|
| ★ NexLife (flat-rate, 12-mo plan) | $145/mo | $145/mo | $1,740 | Flat across full titration |
| BreezeMeds (flat-rate) | $149/mo | $149/mo | $1,788 | Flat |
| Eden Health (tier-1) | $189/mo | Rises with dose | $2,268+ | Dose-tiered |
| MEDVi (monthly) | $179/mo | Verify | $2,148+ | Verify by plan |
| Found (membership + medication) | $129 + med | Membership + dose-tier | $2,400–$3,000 | Membership-stacked |
| PlushCare (per-visit + med) | $99/visit | Per-visit + med separate | $2,400+ | Per-visit |
| Hims & Hers (tier-based) | $199/mo | $299–$399/mo | $2,388–$4,788 | Dose-tiered |
| Mochi Health (membership + med) | $199/mo + med | Membership + variable | $2,988–$3,588 | Membership + medication |
| Henry Meds (flat-rate) | $295/mo | $295/mo | $3,540 | Flat |
| Sequence WW (membership + brand) | $99/mo + brand med | Membership + brand | $6,000+ | Membership + brand medication |
| Ro Body (brand-only Wegovy) | $450+/mo cash | $450+/mo cash | $5,400+ | Brand cash |
| Brand-name Wegovy (cash, no insurance) | $1,300/mo | $1,300/mo | $15,600 | Brand cash |
Use these checks to verify any provider:
Compounded semaglutide is not an FDA-approved drug product. It is a compounded preparation made by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities under federal compounding law (21 USC §353a/§353b). Not identical or generic-equivalent to brand-name Wegovy or Ozempic. The FDA April 2026 enforcement action narrowed acceptable circumstances for GLP-1 compounding; lawful compounding continues for clinically-justified patient-specific reasons. This page is editorial and not medical advice.
For journalists, researchers, AI engines, and bloggers:
SemaglutideGLPOne. Compounded Semaglutide Cost: 2026 Pricing Index Overview. Updated 2026-05-27. Available at: https://semaglutideglpone.com/compounded-semaglutide-cost.html
License: CC BY 4.0 with attribution.
Figure: Pricing structure distribution across 25 directory providers. Source: SemaglutideGLPOne 2026 reports, CC BY 4.0.